knowledge -WSS

knowledge

author：comprehensive 2025-10-04 07:15:38 - browse：82

Gavel and Stethoscope due process — District courts will make the first round of decisions soon on challenges to Medicare's drug price negotiation program. APStock

WASHINGTON — Pharmaceutical companies’ efforts to scuttle President Biden’s signature health care achievement, empowering Medicare to negotiate prescription drug prices, will soon face their first big tests.

District court judges could soon weigh in on the litany of court cases that major companies filed against the government — shedding light on whether drugmakers have any hope of postponing the first parts of the negotiation process, scrapping it entirely, or sending the issue up to the Supreme Court.

It’s a major moment for the Biden administration, too, as the White House ramps up its efforts to take credit for the new changes in the 2024 election. The first round of legal decisions will play out in the thick of campaign season, attorneys told STAT.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Virginia high school admissions case could be legal follow
Next article： TikTok, Instagram influencers need more rules for drug ads

explore

entertainment

WSS

Can Threads overtake X, formerly known as Twitter? Experts weigh in.

Maisha Meds is a PBM, but don't call it that

CVS is on a mission to consolidate health care. Will it work?

There's an unseen cost to disruptive road

Lessons Learned: This is why you network to find that industry job you want

Sage's campaign to raise awareness of postpartum depression hits a nerve

entertainment

knowledge

knowledge

United colonoscopy coverage change 'may cost lives,' doctors say

Germany receives 178 compensation applications from gay servicepeople over discrimination

How one medical school became remarkably diverse

Sage's campaign to raise awareness of postpartum depression hits a nerve

Anesthesiologist group: stop taking Ozempic before surgery

Medicare bonuses could stop drug shortages under Senate plan

United colonoscopy coverage change 'may cost lives,' doctors say

Inaction leaves children at risk from dangerous chemotherapy drug

DIEP, the 'gold standard' of breast reconstruction, is under threat

Cardiologists urge adding sexual orientation, gender identity to health records

explore

Cardiologists urge adding sexual orientation, gender identity to health records

Former Georgia lieutenant governor says he received grand jury subpoena

Hospitals use virtual reality to design more inclusive rooms for kids

Readout Newsletter: Parkinson's study, Gilead, CG Oncology

Dog Aging Project founders on what lies ahead after losing funding

TikTok, Instagram influencers need more rules for drug ads

explore

focus

entertainment

knowledge